Please login to the form below

Not currently logged in

AZ's Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge
Mene Pangalos

AstraZeneca's Mene Pangalos, executive VP of IMED Biotech, has been appointed in two new positions based in Cambridge.

Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK.

In his role as non-executive director, Pangalos will provide a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine.

Additionally, Pangalos has also been appointed an as official fellow of Clare Hall College in the University of Cambridge.

Pangalos said: “I'm delighted to receive these two appointments. Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”    

13th November 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...